In addition to the analysis of the individual polymorphisms in the IL1A, IL1B and IL1RN genes, comparison of the probable haplotype frequencies in the breast cancer and control cohorts did not show any significant differences between the two groups. This evidence concerns the gene IL1RN and breast carcinoma.